NCT03644667

Tocilizumab in Cardiac Transplantation

CompletedPHASE2INTERVENTIONAL

Trial Details

Start: 2018-12-20Est. Completion: 2025-03-25

Enrollment target: 385 participants

Locations

Cedars Sinai Medical Center (CACS), Beverly Hills, California, United States
University of California, San Diego: Sulpizio Cardiovascular Center (CASD), La Jolla, California, United States
Stanford Health Care (CASU), Stanford, California, United States
Tampa General Hospital (FLTG), Tampa, Florida, United States
Northwestern Memorial Hospital (INLM), Chicago, Illinois, United States
Tufts Medical Center (MANM), Boston, Massachusetts, United States
Massachusetts General Hospital (MAMG), Boston, Massachusetts, United States
St. Luke's Hospital of Kansas City (MOLH), Kansas City, Missouri, United States
University of Nebraska Medical Center (NEUN), Omaha, Nebraska, United States
Mount Sinai Medical Center (NYMS), New York, New York, United States
Columbia University Medical Center (NYCP), New York, New York, United States
Montefiore Medical Center (NYMA), The Bronx, New York, United States
Duke University Medical Center (NCDU), Durham, North Carolina, United States
Cleveland Clinic Foundation (OHCC), Cleveland, Ohio, United States

CABGGraft FailureColchicine

This is a single-center, prospective, randomized, open-label, assessor-blinded, blank-controlled exploratory (pilot) tri…

Shanghai, ChinaEst. completion Oct 2027

Biliary CancerBile Duct CancerCancer of the Bile Duct

Background: Biliary tract carcinoma (BTC) is cancer of the slender tubes that carry fluids in the liver. People with ad…

Bethesda, United StatesEst. completion Jun 1, 2040

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.